Abstract | BACKGROUND: METHODS: Two hundred patients entered this prospective, randomized, double-blind trial. Patients received either placebo or cefonicid preoperatively. Loco-regional signs of infection were monitored for 4 weeks postoperatively. RESULTS: There was a trend toward fewer infections in the prophylactic group (placebo 13% versus cefonicid 6%; P = 0.080). Cefonicid significantly decreased severe infections requiring hospitalization (placebo 8% versus cefonicid 1%; P = 0.033). Cefonicid also decreased the treatment cost of infection per patient ($49.80 versus $364.87). CONCLUSIONS: We demonstrated a trend toward fewer overall infections and significantly fewer severe infections in patients given prophylactic antibiotics, which translated into a decrease in the cost of treatment for infectious complications. These findings support antibiotic prophylaxis for patients undergoing ALND.
|
Authors | R J Bold, P F Mansfield, D H Berger, R E Pollock, S E Singletary, F C Ames, C M Balch, D C Hohn, M I Ross |
Journal | American journal of surgery
(Am J Surg)
Vol. 176
Issue 3
Pg. 239-43
(Sep 1998)
ISSN: 0002-9610 [Print] United States |
PMID | 9776150
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antibiotic Prophylaxis
(economics, methods, statistics & numerical data)
- Axilla
- Cefonicid
(administration & dosage, economics)
- Cephalosporins
(administration & dosage, economics)
- Cost-Benefit Analysis
- Double-Blind Method
- Female
- Humans
- Infusions, Intravenous
- Lymph Node Excision
(economics, methods, statistics & numerical data)
- Male
- Middle Aged
- Prospective Studies
- Surgical Wound Infection
(prevention & control)
|